Jason Coloma

Jason Coloma

Directeur Général chez
Maze Therapeutics, Inc.

Fortune : 29 M $ au 30/09/2026

50 ans
Health Technology
Consumer Services
Commercial Services

Profil

Jason V.
Coloma
is currently President, Chief Executive Officer & Director at Maze Therapeutics, Inc. since 2019.
Dr. Coloma is also Director at St. Anthony's Foundation and Director at Braveheart Bio, Inc. starting in 2024.
Former roles include Independent Director at BioAge Labs, Inc. from 2021 to 2024; Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc. from 2016 to 2017; Vice President & Global Head-Oncology Partnering at Roche Diagnostics Corp.
from 2007 to 2016; Chief Business Officer at Insitro, Inc. from 2018 to 2019; and Chief Business Officer at Celsius Therapeutics, Inc. from 2017 to 2018.
Education includes graduate and doctorate degrees from the University of California, Berkeley; an undergraduate degree from the University of San Francisco; and an MBA from the Tuck School of Business at Dartmouth.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
1,22%
06/08/2026 1 100 456 ( 1,22% ) 22 M $ 30/09/2026
0,42%
01/10/2026 234 367 ( 0,42% ) 6 M $ 30/09/2026

Postes actifs de Jason Coloma

SociétésPosteDébut
Directeur Général 01/06/2019
Directeur/Membre du Conseil -

Anciens postes connus de Jason Coloma

SociétésPosteFin
BIOAGE LABS, INC. Directeur/Membre du Conseil 20/08/2024
Corporate Officer/Principal 01/08/2019
Corporate Officer/Principal 01/11/2018
CORVUS PHARMACEUTICALS, INC. Investor Relations Contact 01/07/2017
Corporate Officer/Principal 01/07/2016
Voir l'expérience en détail de Jason Coloma

Formation de Jason Coloma

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Jason Coloma